Last week in Houston, Texas, Kenneth B. Mathis, M.D. implanted Total Joint Orthopedics’ (TJO) 20,000th joint. Just in the last month, TJO added two products to its portfolios, one of which is the Klassic PS-Post System, featuring a bone-sparing low-profile box with revision capabilities.
Total Joint Orthopedics Celebrates 20,000th Implanted Joint

Also, within the last month, George N. Guild, III, M.D., of Atlanta, Georgia, implanted the first BIOLOX CONTOURA ceramic head. The CONTOURA head “offers a contoured and reduced shoulder, an additional option for surgeons, which may alleviate psoas contact and irritation, potentially reducing anterior groin pain in total hip patients.”
“TJO’s model of Efficiency by Design has generated a lot of momentum. I’ve been using their products for more than five years and am excited to be a part of this major milestone,” said Dr. Mathis.
According to Total Joint Orthopedics, the Efficiency by Design model “makes high-quality, efficient implants for hip and knee replacement. Our streamlined instrumentation (only three trays for each surgery) is intuitive and easy to use for reproducible results. It drastically reduces storage costs and the amount of sterile processing needed within hospitals, relieving the burden on surgical staff and sales representatives alike. We use state-of-the-art materials, and our products are manufactured right here in the United States.
Dr. Mathis told OTW, “TJO’s model of Efficiency by Design simplifies everything in the OR from set up through the surgical flow. The instruments are intuitive and eliminate wasted steps. Fewer trays keep my back table organized, mean fewer instruments to re-sterilize, and the surgical staff are happy with the efficiencies. TJO helps make my surgery days run smoothly.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.